Search Results - "Allard, Christopher Brian"

The impact of histological variants on bladder cancer survival: A population-based analysis by Gelpi-Hammerschmidt, Francisco, Rodriguez, Dayron, Tinay, Ilker, Allard, Christopher Brian, Blute, Michael, Kibel, Adam S., Chang, Steven Lee, Trinh, Quoc-Dien, Preston, Mark A

“…Abstract only 458 Background: We evaluated the clinical and prognostic impact of bladder cancer histologic variants (BCHV) using a large population-based…”
Get full text

High-intensity focused ultrasound (HIFU) as salvage therapy for radio-recurrent prostate cancer: Predictors of disease response by Dason, Shawn, Allard, Christopher Brian, Hoogenes, Jen, Orovan, William, Shayegan, Bobby

“…Abstract only 135 Background: Some patients with localized radio-recurrent prostate cancer (PCa) may have long-term recurrence-free (RFS) survival with salvage…”
Get full text

Regular aspirin use and the risk of lethal prostate cancer in the Physicians' Health Study by Allard, Christopher Brian, Downer, Mary K, Preston, Mark A, Gaziano, J. Michael, Stampfer, Meir J., Mucci, Lorelei A., Batista, Julie

“…Abstract only 306 Background: Aspirin exerts chemopreventive effects against several malignancies. An inverse association between regular aspirin intake and…”
Get full text

Transurethral (TURP) biopsy of suspected anterior prostate cancers identified by MRI: Pilot study of a novel technique by Dason, Shawn, Allard, Christopher Brian, Barrett, Keith, Wright, Ian, Shayegan, Bobby

“…Abstract only 230 Background: Prostatic MRI allows for identification of cancerous lesions in patients with a prior negative TRUS biopsy. Although in-gantry…”
Get full text

Testosterone suppression: Impact of testosterone level on disease progression in advanced prostate cancer by Dason, Shawn, Tong, Justin, Allard, Christopher Brian, Shayegan, Bobby

“…Abstract only 46 Background: In patients with advanced prostate cancer, medical castration remains a mainstay of treatment. A testosterone level below 50 ng/dL…”
Get full text

Intermittent androgen deprivation therapy for prostate cancer: translating randomized controlled trials into clinical practice by Dason, Shawn, Allard, Christopher Brian, Wang, Jing Gennie, Hoogenes, Jen, Shayegan, Bobby

“…Intermittent androgen deprivation therapy (IADT) for prostate cancer involves cycles of androgen deprivation therapy (ADT) with a period between cycles where…”
Get more information